This issue is dedicated to exploring technologies that can improve your patients’ lives and your practice.
Innovations in medical tools and technologies have revolutionized women’s health care. This issue explores technologies that can improve your patients’ lives.
Several prominent experts, led by Deputy Editor Jon I. Einarsson, MD, MDH, PhD, contributed their unique perspectives to articles in this issue. Together with Robert Zurawin, MD, and Gaby Moawad, MD, Dr. Einarsson engages in a pros-and-cons discussion of gynecologic surgical approaches and the latest technologies. The question persists: Why isn’t vaginal hysterectomy the more widely used approach? What if it is made more accessible via technology? The full video interview is available here.
For more than 100 years, the Austrians and the Germans dominated the world of vaginal hysterectomy, said Dr. Zurawin, because they realized its advantages to reduce the infection and bleeding seen in the abdominal approach, with very high morbidity and mortality. Dr. Zurawin has spoken of Dr. Noble Sproat Heaney, who popularized vaginal hysterectomy in 1934 with instruments he designed, which are used today.
What is the next evolution in technology that will allow ob/gyns to safely and effectively perform gynecological procedures? Much is in progress.
Let us know your thoughts about technologies that have improved your practice by emailing our editorial staff at COGeditorial@mmhgroup.com.
Severe maternal morbidity linked to mental health risks post-delivery
April 26th 2024A recent study revealed that severe maternal morbidity during pregnancy increases the likelihood of mental health hospitalizations or emergency department visits up to 13 years post-delivery, emphasizing the need for mental health screening.
Read More
FDA approves updated label for Biktarvy against HIV-1
April 26th 2024Gilead Sciences has announced FDA approval of an updated Biktarvy label, showcasing safety and efficacy data from a phase 1b trial, positioning it as a pivotal treatment option for pregnant individuals with HIV-1 and suppressed viral load.
Read More
No link found between antenatal corticosteroids and child neurodevelopment
April 25th 2024A recent study found no link between antenatal corticosteroid administration and adverse neurodevelopmental outcomes in children aged 6 years or older, offering reassurance for late preterm delivery practices.
Read More